What happened, in summary

A 78-year-old man presented with shortness of breath, weakness, difficulty walking and swallowing, and an erythematous facial rash. Chest imaging showed a lung mass and enlarged lymph nodes, and biopsy confirmed small cell lung cancer. He also had muscle and soft-tissue inflammation, elevated muscle enzymes, and biopsy findings consistent with dermatomyositis. Positive anti-TIF1-gamma testing supported cancer-associated dermatomyositis as a paraneoplastic condition. He began carboplatin, etoposide, and atezolizumab for the lung cancer, together with steroids for the dermatomyositis. After treatment started, his muscle-enzyme levels fell and he had a notable improvement in strength, skin symptoms, and overall condition. His course highlights how a paraneoplastic autoimmune condition can improve alongside systemic cancer treatment, while still requiring close monitoring during immunotherapy.